ID   KCC-TCM901
AC   CVCL_7966
SY   KCC TCM901
DR   Cosmic; 1136965
DR   Cosmic; 1556194
DR   Wikidata; Q54899635
RX   PubMed=18097577;
RX   PubMed=21362583;
RX   PubMed=21631644;
RX   PubMed=26780976;
RX   PubMed=26781072;
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=26780976; PubMed=26781072). Originally thought to originate from a lung metastasis of a tongue squamous cell carcinoma.
CC   Population: African American.
CC   Doubling time: 12.59 hours (PubMed=21362583).
CC   HLA typing: A*68:02 (Direct_author_submission).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
RX   PubMed=18097577; DOI=10.3892/or.19.1.65;
RA   Taguchi, Takahide
RA   Tsukuda, Mamoru
RA   Imagawa-Ishiguro, Yukari
RA   Kato, Yasumasa
RA   Sano, Daisuke
RT   "Involvement of EGFR in the response of squamous cell carcinoma of the
RT   head and neck cell lines to gefitinib.";
RL   Oncol. Rep. 19:65-71(2008).
//
RX   PubMed=21362583; DOI=10.1016/j.anl.2011.01.018;
RA   Sakakibara, Atsuko
RA   Tsukuda, Mamoru
RA   Kondo, Norio
RA   Ishiguro, Yukari
RA   Kimura, Machiko
RA   Fujita, Kyoko
RA   Takahashi, Hideaki
RA   Matsuda, Hideki
RT   "Examination of the optimal condition on the in vitro sensitivity to
RT   telomelysin in head and neck cancer cell lines.";
RL   Auris Nasus Larynx 38:589-599(2011).
//
RX   PubMed=26781072; DOI=10.3892/or.2016.4574;
RA   Sano, Daisuke
RA   Kawakami, Mariko
RA   Fujita, Kyoko
RA   Kimura, Machiko
RA   Yamashita, Yukiko
RA   Ishiguro, Yukari
RA   Nishimura, Goshi
RA   Matsuda, Hideki
RA   Tsukuda, Mamoru
RT   "Corrigendum to 'Antitumor effects of ZD6474 on head and neck squamous
RT   cell carcinoma'.";
RL   Oncol. Rep. 35:2495-2495(2016).
//
RX   PubMed=21631644; DOI=10.1111/j.1349-7006.2011.01999.x;
RA   Kondo, Norio
RA   Tsukuda, Mamoru
RA   Taguchi, Takahide
RA   Nakazaki, Kouichi
RA   Sakakibara, Atsuko
RA   Takahashi, Hideaki
RA   Toth, Gabor
RA   Nishimura, Goshi
RT   "Gene status of head and neck squamous cell carcinoma cell lines and
RT   cetuximab-mediated biological activities.";
RL   Cancer Sci. 102:1717-1723(2011).
//
RX   PubMed=26780976; DOI=10.3892/or.2016.4573;
RA   Sano, Daisuke
RA   Matsuda, Hideki
RA   Ishiguro, Yukari
RA   Nishimura, Goshi
RA   Kawakami, Mariko
RA   Tsukuda, Mamoru
RT   "Corrigendum to 'Antitumor effects of IDN5109 on head and neck squamous
RT   cell carcinoma'.";
RL   Oncol. Rep. 35:2494-2494(2016).
//